ArticleClinical immunology (Orlando, Fla.)2020
Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19.
Jeffrey Laurence et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
77 papers cite itlatest 60 shown
this paperpooled ittrialcites it